A study in Diabetic Medicine found that 40% of older adults with type 2 diabetes initially declined insulin therapy advised by their doctors, and they had poorer glycemic control and a longer time to reach optimal blood glucose levels, compared with those who began insulin therapy. The researchers, who evaluated 15 years of health data from 5,307 adults with type 2 diabetes, also discovered that delaying insulin therapy could shorten one's life span.
Study: 40% of diabetes patients decline insulin therapy
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.